Advanced Search
REVIEW ARTICLE
Korean J Pediatr 2011 May;54(5) :197-200.
doi:https://doi.org/10.3345/kjp.2011.54.5.197
Respiratory syncytial virus prevention in children with congenital heart disease: who and how?
Nam Kyun Kim (Kim NK)1, Jae Young Choi (Choi JY)1
Corresponding Author: Jae Young Choi ,Tel: +82-2-2228-8473, Fax: +82-2-312-9583, Email: cjy0122@yuhs.ac
Copyright © 2011 by The Korean Pediatric Society
ABSTRACT
Respiratory syncytial virus (RSV) is a major cause of respiratory infection in children. Most of the pediatric population have RSV infection before the age of 2, and recurrent infections are common even within one season. Chronic lung disease, prematurity, along with congenital heart disease (CHD) are major risk factors in severe lower respiratory infection. In hemo-dynamically significant CHD patients with RSV infection, hospitalization is usually needed and the possibility of treatment in intensive care unit and the use of mechanical ventilator support are known to increase. Therefore the prevention of RSV infection in CHD patients is mandatory. The current standard for RSV prevention is immunoprophylaxis by palivizumab. Immunoprophylaxis is recommended monthly in hemodynamically significant CHD patients, up to 5 months. Motabizumab, a second generation drug and newly developing RSV vaccines are also expected to play a key role in RSV prevention in the future. The prophylaxis of RSV infection in CHD patients is cost-effective in both the medical aspect of the patients as well as the socio-economic aspect. Therefore an effort to promote prevention should be made by not only the family of the patients but also by the government.
Keywords: Respiratory syncytial virus | Congenital heart defect | Prevention | Child
TOOLS
PDF Links  PDF Links
Full text via DOI  Full text via DOI
  via Pubmed
Full text via PMC  Full text via PMC
via Pubreader  via PubReader
Download Citation  Download Citation
Supplementary Material  Supplementary Material
  E-Mail
Share:      
METRICS
1,476
View
12
Download
Psychosocial adjustment and quality of life of adolescents and adults with congenital heart disease  2014 June;57(6)
Effectiveness and safety of seasonal influenza vaccination in children with underlying respiratory diseases and allergy  2014 April;57(4)
Myocardial atrophy in children with mitochondrial disease and Duchenne muscular dystrophy  2014 May;57(5)
Right ventricular failure in congenital heart disease  2013 March;56(3)
Respiratory syncytial virus infection in children with congenital heart disease: global data and interim results of Korean RSV-CHD survey  2011 May;54(5)
Register for e-submission
Register here to access the e-submission system of Korean J Pediatr for authors and reviewers.
Manuscript Submission
To submit a manuscript, please visit the Korean J Pediatr e-submission management system at http://submit.kjp.or.kr, read the Instructions for Authors, and log into the Korean J Pediatr e-submission system. For assistance with manuscript submission, please contact: kjpped@gmail.com.
Free archive
Anyone may access any past or current articles without logging in.
Korean Pediatric Society Office
#1606, Seocho World Officetel, 19 Seoun-ro, Seocho-gu, Seoul 137-070, Korea
TEL : +82-2-3473-7305    FAX : +82-2-3473-7307   E-mail: kjpped@gmail.com
BrowseCurrent IssueFor Authors and ReviewersAbout
Copyright© The Korean Pediatric Society. All right reserved.